AnalystsInsight

Christopher Marinac (Brean Capital): Analyst Track Record and Price‑Target Accuracy

How often Christopher Marinac’s price targets were reached, how fast, and what the stocks did after each call: a 7‑year backtest of 151 ratings, compared with the average Wall Street analyst.

Published Updated 3 min readHow we research

What changed since Nov 9

Exent re-checks this page every day. Ratings appear 30 days after they are published; live calls are in Gems.

+3 new ratings (RF, COSO)1 upgrade+2 stocks newly covered

Key takeaways

  • Christopher Marinac ranks #985 of 1,191 analysts in Exent’s scoring (4.6★).
  • 53.0% of price targets were reached over 7 years, versus 53.0% for the average analyst.
  • Median time to reach a target: 172 days; 58.5% of calls were up 12 months later.
  • Most‑covered stocks: SFST, BCBP, FGBI, FHN.
  • Free on Exent: Christopher Marinac’s full record, with ratings 3 days after publication.

Which stocks do Wall Street’s best‑ranked analysts agree on? See them in Exent Gems →

Christopher Marinac’s track record at a glance

Christopher Marinac of Brean Capital ranks #985 of the 1,191 analysts Exent scores, with a 4.6★ rating and a focus on financials. Over a 7‑year lookback, 53.0% of Christopher’s price targets were reached, 0.0 points below the 53.0% average across all analysts.

MetricChristopher MarinacAll analysts
Price‑target hit rate53.0%53.0%
Median days to hit target172 days93 days
Calls up after 12 months58.5%64.4%
Median 12‑month return of calls+11.6%+13.6%
Hit rate, last 2 years51.7%—
Average worst drop after a call−16.1%—
Ratings in the sample151—
Stocks covered37—

The full records of Exent’s top 50 analysts and the top 50 of each sector, and the stocks where several of them agree right now, are members‑only in Exent Gems.

How fast price targets were reached

Time to reach the targetChristopher Marinac
Under 30 days4.6%
30–90 days15.9%
90–180 days43.2%
Over 180 days36.4%

Share of the targets that were reached, by how long they took. Targets are usually set for 12 months.

Stocks Christopher Marinac covers most

StockRatings in the sample
SFST12
BCBP11
FGBI10
FHN10
UCB9
FBNC8
RF7
FITB7

In the past year Christopher’s ratings were 58% Buy, 42% Hold and 0% Sell.

Exent’s top 50 analysts

Across 988,127 ratings, the average Wall Street analyst’s price target was reached 53.0% of the time: close to a coin flip. The spread between analysts is wide, and 14.4% of the 971 analysts with a measurable record reached 70% or more (Exent data, Nov 16, 2026).

Exent Gems is built on the top 50 of Exent’s ranking. Over the last two years, some of them reached 90% or more of their price targets. Who they are, which stocks they are calling now and how often they have been right is for members.

Christopher Marinac’s latest ratings

DateStockActionRatingPrice target
Oct 19, 2026RFUpgraded: BuyBuy$33.00
Oct 13, 2026COSOInitiated Coverage: BuyBuy$33.00
Oct 13, 2026COSOInitiated: BuyBuy$33.00
Sep 18, 2026BCBPDowngraded: HoldHold$9.00
Jun 12, 2026SFSTInitiated Coverage: HoldHold$67.00
Jun 8, 2026FBNCInitiated CoverageHold$65.75
Jun 8, 2026FBNCInitiated Coverage: HoldHold$65.75
May 20, 2026PDLBInitiated Coverage: BuyBuy$24.00
May 20, 2026PDLBInitiated CoverageBuy$24.00
Apr 22, 2026NPBInitiated Coverage: HoldHold$20.25
Apr 22, 2026NPBInitiated CoverageHold$20.25
Apr 21, 2026UNTYInitiated CoverageBuy$61.00
  • Oct 19, 2026
    Stock
    RF
    Action
    Upgraded: Buy
    Rating
    Buy
    Price target
    $33.00
  • Oct 13, 2026
    Stock
    COSO
    Action
    Initiated Coverage: Buy
    Rating
    Buy
    Price target
    $33.00
  • Oct 13, 2026
    Stock
    COSO
    Action
    Initiated: Buy
    Rating
    Buy
    Price target
    $33.00
  • Sep 18, 2026
    Stock
    BCBP
    Action
    Downgraded: Hold
    Rating
    Hold
    Price target
    $9.00
  • Jun 12, 2026
    Stock
    SFST
    Action
    Initiated Coverage: Hold
    Rating
    Hold
    Price target
    $67.00
  • Jun 8, 2026
    Stock
    FBNC
    Action
    Initiated Coverage
    Rating
    Hold
    Price target
    $65.75
  • Jun 8, 2026
    Stock
    FBNC
    Action
    Initiated Coverage: Hold
    Rating
    Hold
    Price target
    $65.75
  • May 20, 2026
    Stock
    PDLB
    Action
    Initiated Coverage: Buy
    Rating
    Buy
    Price target
    $24.00
  • May 20, 2026
    Stock
    PDLB
    Action
    Initiated Coverage
    Rating
    Buy
    Price target
    $24.00
  • Apr 22, 2026
    Stock
    NPB
    Action
    Initiated Coverage: Hold
    Rating
    Hold
    Price target
    $20.25
  • Apr 22, 2026
    Stock
    NPB
    Action
    Initiated Coverage
    Rating
    Hold
    Price target
    $20.25
  • Apr 21, 2026
    Stock
    UNTY
    Action
    Initiated Coverage
    Rating
    Buy
    Price target
    $61.00

Christopher’s ratings are free on Exent 3 days after publication. Exent Gems has them the same day, with the calls of the top‑ranked analysts and the stocks where several of them agree.

More analysts to compare

How Exent scores analysts

Exent replays every rating with a price target over a 7‑year lookback: was the target reached, how long it took, and what the stock returned 1, 3, 6 and 12 months after the call. The star rating and rank combine success rate, average return and the number of ratings, so a few lucky calls do not make a top analyst. Statistics as of Nov 16, 2026; ranking updated Nov 19, 2026. How accurate are analyst price targets overall?

Past performance does not guarantee future results. Historical figures are calculated by Exent from market data and are for education only; they are not investment advice or a recommendation to buy or sell any security.

Follow the analysts with the best records

  1. Exent Gems shows live ratings from the top‑ranked analysts, without the 3‑day delay used on this page.
  2. Gems are the stocks where several 4★+ analysts agree: Exent’s shortlist of high‑conviction ideas.
  3. Check any idea against your own portfolio: correlation, concentration and crash exposure before you buy.

Exent is our product. Educational content, not investment advice.

Frequently asked questions

By Exent’s scoring Christopher Marinac ranks #985 of 1,191 with a 4.6★ rating. 53.0% of price targets were reached over a 7-year lookback (all analysts: 53.0%), and 58.5% of calls were up 12 months later. Past accuracy does not guarantee future accuracy.

In Exent’s 7-year price-target backtest, 53.0% of Christopher Marinac’s price targets were reached, with a median of 172 days to reach a target (all analysts: 53.0%).

Christopher Marinac (Brean Capital) covers 37 stocks, mostly in financials. The most frequently rated are SFST, BCBP, FGBI, FHN, UCB.

Get the picks Wall Street’s best analysts agree on.

Exent tracks 4,000+ analysts, keeps only the elite few with proven records, and surfaces the Gems where they agree.

See this week’s GemsLimited offer$1.95 for full access· full access

Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.

DISCLAIMER: Exent AI is an informational research platform and does not provide investment advice, financial advice, or act as an investment adviser, broker-dealer, or fiduciary. All content, analytics, and model outputs are provided for educational and informational purposes only and should not be relied upon as a recommendation to buy, sell, or hold any financial instrument. Investing involves risk, including the possible loss of principal. Exent AI does not execute trades, hold customer funds, or provide brokerage services. Past performance and hypothetical results are not indicative of future results. Third-party data and AI-generated outputs may be incomplete or inaccurate.